Wim J. Sluiter

12.9k total citations · 1 hit paper
252 papers, 9.8k citations indexed

About

Wim J. Sluiter is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Wim J. Sluiter has authored 252 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 68 papers in Surgery and 55 papers in Molecular Biology. Recurrent topics in Wim J. Sluiter's work include Pituitary Gland Disorders and Treatments (23 papers), Thyroid Cancer Diagnosis and Treatment (18 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). Wim J. Sluiter is often cited by papers focused on Pituitary Gland Disorders and Treatments (23 papers), Thyroid Cancer Diagnosis and Treatment (18 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). Wim J. Sluiter collaborates with scholars based in Netherlands, United States and Germany. Wim J. Sluiter's co-authors include Elisabeth G.E. de Vries, Robin P. F. Dullaart, Arie van Tol, Thera P. Links, Robin P.F. Dullaart, Anneke Pietersma, Pieter L. Jager, Johan F. Koster, Bruce H. R. Wolffenbuttel and J.F. Koster and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Wim J. Sluiter

252 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer

2008 509 citations Ate G.J. van der Zee, Wim J. Sluiter et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wim J. Sluiter Netherlands	55	2.8k	2.2k	2.0k	1.9k	1.6k	252	9.8k
Enyu Imai Japan	61	3.0k 1.1×	4.8k 2.2×	2.3k 1.2×	1.6k 0.9×	926 0.6×	324	18.7k
Laurel A. Habel United States	47	2.0k 0.7×	3.2k 1.5×	1.4k 0.7×	1.1k 0.6×	3.7k 2.4×	200	9.9k
Andrew D. Blann United Kingdom	71	2.2k 0.8×	3.5k 1.6×	1.0k 0.5×	2.0k 1.0×	1.7k 1.1×	338	15.5k
Nobuoki Kohno Japan	67	1.7k 0.6×	3.9k 1.8×	957 0.5×	1.9k 1.0×	2.4k 1.5×	365	14.3k
Kevin E. Bove United States	49	2.5k 0.9×	2.3k 1.1×	588 0.3×	1.4k 0.7×	1.2k 0.8×	215	8.3k
Koutaro Yokote Japan	47	2.8k 1.0×	4.6k 2.1×	3.6k 1.8×	1.1k 0.6×	952 0.6×	337	12.1k
Christine Sempoux Belgium	52	4.4k 1.5×	1.8k 0.8×	1.6k 0.8×	2.8k 1.4×	2.6k 1.7×	314	9.9k
Uichi Ikeda Japan	57	3.6k 1.3×	5.0k 2.3×	889 0.4×	1.1k 0.6×	1.4k 0.9×	379	12.6k
Joseph P. Grande United States	71	2.8k 1.0×	4.2k 1.9×	618 0.3×	939 0.5×	1.1k 0.7×	284	15.0k
Hideo A. Baba Germany	51	2.5k 0.9×	4.1k 1.9×	606 0.3×	1.4k 0.7×	1.6k 1.0×	346	10.4k

Countries citing papers authored by Wim J. Sluiter

Since Specialization

Citations

This map shows the geographic impact of Wim J. Sluiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim J. Sluiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim J. Sluiter more than expected).

Fields of papers citing papers by Wim J. Sluiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim J. Sluiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim J. Sluiter. The network helps show where Wim J. Sluiter may publish in the future.

Co-authorship network of co-authors of Wim J. Sluiter

This figure shows the co-authorship network connecting the top 25 collaborators of Wim J. Sluiter. A scholar is included among the top collaborators of Wim J. Sluiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim J. Sluiter. Wim J. Sluiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, Boukje A. C. van, et al.. (2022). The outcome of treatment in differentiated thyroid cancer according to recommendations in current Dutch and American guidelines. Clinical Endocrinology. 98(1). 123–130. 3 indexed citations

Berends, Annika M.A., Edward Buitenwerf, Eke G. Gruppen, et al.. (2018). Primary aldosteronism is associated with decreased low‐density and high‐density lipoprotein particle concentrations and increased GlycA, a pro‐inflammatory glycoprotein biomarker. Clinical Endocrinology. 90(1). 79–87. 17 indexed citations

Gruppen, Eke G., Margery A. Connelly, Wim J. Sluiter, Stephan J. L. Bakker, & Robin P. F. Dullaart. (2018). Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study. Clinica Chimica Acta. 488. 7–12. 18 indexed citations

Berg, Gerrit van den, Antonius E. van Herwaarden, Anneke C. Muller Kobold, et al.. (2018). Postoperative use of somatostatin analogs and mortality in patients with acromegaly. European Journal of Endocrinology. 180(1). 1–9. 4 indexed citations

Horst‐Schrivers, Anouk N.A. van der, Wim J. Sluiter, Anneke C. Muller Kobold, et al.. (2015). Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study. PLoS ONE. 10(3). e0120184–e0120184. 2 indexed citations

Kruizinga, Roeliene C., Wim J. Sluiter, Elisabeth G.E. de Vries, et al.. (2013). Calculating optimal surveillance for detection of von Hippel–Lindau-related manifestations. Endocrine Related Cancer. 21(1). 63–71. 38 indexed citations

Sattler, M., André P. van Beek, Bruce H. R. Wolffenbuttel, et al.. (2012). The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiotherapy and Oncology. 104(1). 125–130. 37 indexed citations

Netea‐Maier, Romana T., et al.. (2011). Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. 26. 1 indexed citations

Bosch, B.J.C. van den, Mike Gerards, Wim J. Sluiter, et al.. (2011). Defective NDUFA9 as a novel cause of neonatally fatal complex I disease. Journal of Medical Genetics. 49(1). 10–15. 46 indexed citations

10.

Azzouzi, Hamid el, Ralph J. van Oort, Roel van der Nagel, et al.. (2009). MEF2 Transcriptional Activity Maintains Mitochondrial Adaptation in Cardiac Pressure Overload. European Journal of Heart Failure. 12(1). 4–12. 22 indexed citations

11.

Koopmans, Klaas Pieter, Oliver Neels, Ido P. Kema, et al.. (2008). Improved Staging of Patients With Carcinoid and Islet Cell Tumors With ¹⁸F-Dihydroxy-Phenyl-Alanine and ¹¹C-5-Hydroxy-Tryptophan Positron Emission Tomography. Journal of Clinical Oncology. 26(9). 1489–1495. 163 indexed citations

12.

Raa, Sander Ten, et al.. (2007). The Influence of Reactive Oxygen Species on the Adhesion of Pancreatic Carcinoma Cells to the Peritoneum. Cell Adhesion & Migration. 1(2). 77–83. 10 indexed citations

13.

Lambeck, Annechien J.A., Ninke Leffers, Baukje‐Nynke Hoogeboom, et al.. (2007). P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy. International Journal of Cancer. 121(3). 606–614. 31 indexed citations

14.

Zijlstra, Josée M., Wim J. Sluiter, Gustaaf W. van Imhoff, et al.. (2006). Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood. 109(2). 486–491. 96 indexed citations

15.

Empel, Vanessa van, A. Bertrand, Ralph J. van Oort, et al.. (2006). EUK-8, a Superoxide Dismutase and Catalase Mimetic, Reduces Cardiac Oxidative Stress and Ameliorates Pressure Overload-Induced Heart Failure in the Harlequin Mouse Mutant. Journal of the American College of Cardiology. 48(4). 824–832. 103 indexed citations

16.

Mulder, Nanno H., Wim J. Sluiter, Coby Meijer, et al.. (2005). Influence of p53 Status on the HSV-Tk/GCV-Induced Bystander Effect in a Panel of Human Ovarian Carcinoma Cell Lines. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 15(3). 151–159. 3 indexed citations

17.

Mulder, Nanno H., Wim J. Sluiter, Coby Meijer, et al.. (2005). Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.. PubMed. 25(1A). 255–61. 6 indexed citations

18.

Hovenga, Sjoerd, Simon Daenen, J. Th. M. de Wolf, et al.. (2004). Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study. Annals of Hematology. 84(5). 311–316. 28 indexed citations

19.

Riemens, S. C., Arie van Tol, Wim J. Sluiter, & Robin P. F. Dullaart. (1998). Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis. 140(1). 71–79. 103 indexed citations

20.

Bilo, H. J. G., et al.. (1990). Dietary supplementation with fish oil modifies renal reserve filtration capacity in postoperative, cyclosporin A-treated renal transplant recipients. Transplant International. 3(3). 171–175. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact